Article
Serratia Endocarditis in Patients with a Starr‐Edwards Valve Report ot a Case of Bacteriologic Cure with Antimicrobial Therapy
Abstract
AbstractAlthough rare, Serratia marcescens endocarditis has been reported in patients after surgical placement of a Starr-Edwards valve. Of four previously reported patients only one survived. In the present case report, bacteriologic cure was achieved by antimicrobial therapy alone. Artificial valve endocarditis of this type may be managed without resorting to valve replacement if hemodynamic deterioration does not occur and if an antimicrobial agent can be identified which will kill the organism in vitro in levels that can be achieved clinically. Carbenicillin is potentially useful for treating serious Serratia infections.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.